Loading…

Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder

Objective To study PDE5 localisation by visualising the product of phosphodiesterase type 5 (PDE5) inhibition, namely cGMP, to determine the site of action of inhibitors in the urinary bladder. Materials and Methods Bladders of nine male guinea pigs were dissected and treated in wells containing 2 m...

Full description

Saved in:
Bibliographic Details
Published in:BJU international 2013-07, Vol.112 (2), p.246-257
Main Authors: Rahnama'i, Mohammad S., Koeveringe, Gommert A., Hohnen, Ramona, Ona, Samsya, Kerrebroeck, Philip E.V., Wachter, Stefan G.G.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293
cites cdi_FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293
container_end_page 257
container_issue 2
container_start_page 246
container_title BJU international
container_volume 112
creator Rahnama'i, Mohammad S.
Koeveringe, Gommert A.
Hohnen, Ramona
Ona, Samsya
Kerrebroeck, Philip E.V.
Wachter, Stefan G.G.
description Objective To study PDE5 localisation by visualising the product of phosphodiesterase type 5 (PDE5) inhibition, namely cGMP, to determine the site of action of inhibitors in the urinary bladder. Materials and Methods Bladders of nine male guinea pigs were dissected and treated in wells containing 2 mL Krebs' solution and 1 μM of the specific PDE5 inhibitor vardenafil at 36 °C for 30 min. After stimulating tissues with 100 μM of the nitric oxide (NO) donor diethylamine‐NONOate for 10 min, the tissues were snap‐frozen and 9–10 μm sections were cut. Sections were examined for cGMP immunoreactivity and also stained for vimentin, a marker for interstitial cells and the neuromarkers protein gene product 9.5 (PGP9.5), synaptic vesicle protein 2 (SV2), neurofilament (NF) and calcitonin gene‐related peptide (CGRP), using the two‐step indirect immunohistochemistry technique. Results After PDE5 inhibition, cGMP was found to be present in the urothelium, suburothelial interstitial cells and endothelium of blood vessels. cGMP was not expressed in nerves positive for CGRP, NF and SV2, and was expressed only in very few efferent nerves positive for PGP9.5. Conclusion Our data show that the possible sites of action of PDE5 inhibition in the bladder are the urothelium, suburothelial interstitial cells and blood vessels, rather than the bladder nerve fibres.
doi_str_mv 10.1111/bju.12031
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1372080185</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3104433491</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293</originalsourceid><addsrcrecordid>eNp10FtLBCEUAGCJovtDfyCECOphSx2dHR-7XwjqoaA3cfRMubgzk86w7L_PabeCIEGU4-c5ehDao-SEpnFaTvoTykhGV9Am5TkfcUpeV7_3ROYbaCvGCSEpkIt1tMEyLhhj-SaCSxe74Mq-c02Nmwq3701M0zqIHQQdAXfzFrDAR0-XV-IYuxp374C9Hk49nmnvh2tD7K13NWjcujfcB1frMMel19ZC2EFrlfYRdpfrNnq5vnq-uB09PN7cXZw9jAwvOB0JOeamyHNZUSlMZnlprBGlBKtFYblkpTQWDBMk58JakaghIumKg5FMZtvoaJG3Dc1Hn36gpi4a8F7X0PRR0WzMSEFoIRI9-EMnTR_q9DpFOc8E4VQM6nihTGhiDFCpNrhp-pmiRA29V6n36qv3ye4vM_blFOyP_G52AodLoKPRvgq6Ni7-ujHPJZdFcqcLN3Me5v9XVOf3L4vSn8urmTA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1443504155</pqid></control><display><type>article</type><title>Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Rahnama'i, Mohammad S. ; Koeveringe, Gommert A. ; Hohnen, Ramona ; Ona, Samsya ; Kerrebroeck, Philip E.V. ; Wachter, Stefan G.G.</creator><creatorcontrib>Rahnama'i, Mohammad S. ; Koeveringe, Gommert A. ; Hohnen, Ramona ; Ona, Samsya ; Kerrebroeck, Philip E.V. ; Wachter, Stefan G.G.</creatorcontrib><description>Objective To study PDE5 localisation by visualising the product of phosphodiesterase type 5 (PDE5) inhibition, namely cGMP, to determine the site of action of inhibitors in the urinary bladder. Materials and Methods Bladders of nine male guinea pigs were dissected and treated in wells containing 2 mL Krebs' solution and 1 μM of the specific PDE5 inhibitor vardenafil at 36 °C for 30 min. After stimulating tissues with 100 μM of the nitric oxide (NO) donor diethylamine‐NONOate for 10 min, the tissues were snap‐frozen and 9–10 μm sections were cut. Sections were examined for cGMP immunoreactivity and also stained for vimentin, a marker for interstitial cells and the neuromarkers protein gene product 9.5 (PGP9.5), synaptic vesicle protein 2 (SV2), neurofilament (NF) and calcitonin gene‐related peptide (CGRP), using the two‐step indirect immunohistochemistry technique. Results After PDE5 inhibition, cGMP was found to be present in the urothelium, suburothelial interstitial cells and endothelium of blood vessels. cGMP was not expressed in nerves positive for CGRP, NF and SV2, and was expressed only in very few efferent nerves positive for PGP9.5. Conclusion Our data show that the possible sites of action of PDE5 inhibition in the bladder are the urothelium, suburothelial interstitial cells and blood vessels, rather than the bladder nerve fibres.</description><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1111/bju.12031</identifier><identifier>PMID: 23452226</identifier><identifier>CODEN: BJINFO</identifier><language>eng</language><publisher>Oxford: Wiley-Blackwell</publisher><subject>Animals ; Biological and medical sciences ; cGMP ; Cyclic Nucleotide Phosphodiesterases, Type 5 - analysis ; Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism ; detrusor ; guinea pig ; Guinea Pigs ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; phosphodiesterase inhibitor type 5 (PDE5) ; urinary bladder ; Urinary Bladder - chemistry ; Urinary Bladder - metabolism ; vardenafil</subject><ispartof>BJU international, 2013-07, Vol.112 (2), p.246-257</ispartof><rights>2013 BJU International</rights><rights>2014 INIST-CNRS</rights><rights>2013 BJU International.</rights><rights>BJUI © 2013 BJU International</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293</citedby><cites>FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27469498$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23452226$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rahnama'i, Mohammad S.</creatorcontrib><creatorcontrib>Koeveringe, Gommert A.</creatorcontrib><creatorcontrib>Hohnen, Ramona</creatorcontrib><creatorcontrib>Ona, Samsya</creatorcontrib><creatorcontrib>Kerrebroeck, Philip E.V.</creatorcontrib><creatorcontrib>Wachter, Stefan G.G.</creatorcontrib><title>Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder</title><title>BJU international</title><addtitle>BJU Int</addtitle><description>Objective To study PDE5 localisation by visualising the product of phosphodiesterase type 5 (PDE5) inhibition, namely cGMP, to determine the site of action of inhibitors in the urinary bladder. Materials and Methods Bladders of nine male guinea pigs were dissected and treated in wells containing 2 mL Krebs' solution and 1 μM of the specific PDE5 inhibitor vardenafil at 36 °C for 30 min. After stimulating tissues with 100 μM of the nitric oxide (NO) donor diethylamine‐NONOate for 10 min, the tissues were snap‐frozen and 9–10 μm sections were cut. Sections were examined for cGMP immunoreactivity and also stained for vimentin, a marker for interstitial cells and the neuromarkers protein gene product 9.5 (PGP9.5), synaptic vesicle protein 2 (SV2), neurofilament (NF) and calcitonin gene‐related peptide (CGRP), using the two‐step indirect immunohistochemistry technique. Results After PDE5 inhibition, cGMP was found to be present in the urothelium, suburothelial interstitial cells and endothelium of blood vessels. cGMP was not expressed in nerves positive for CGRP, NF and SV2, and was expressed only in very few efferent nerves positive for PGP9.5. Conclusion Our data show that the possible sites of action of PDE5 inhibition in the bladder are the urothelium, suburothelial interstitial cells and blood vessels, rather than the bladder nerve fibres.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>cGMP</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 5 - analysis</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism</subject><subject>detrusor</subject><subject>guinea pig</subject><subject>Guinea Pigs</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>phosphodiesterase inhibitor type 5 (PDE5)</subject><subject>urinary bladder</subject><subject>Urinary Bladder - chemistry</subject><subject>Urinary Bladder - metabolism</subject><subject>vardenafil</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNp10FtLBCEUAGCJovtDfyCECOphSx2dHR-7XwjqoaA3cfRMubgzk86w7L_PabeCIEGU4-c5ehDao-SEpnFaTvoTykhGV9Am5TkfcUpeV7_3ROYbaCvGCSEpkIt1tMEyLhhj-SaCSxe74Mq-c02Nmwq3701M0zqIHQQdAXfzFrDAR0-XV-IYuxp374C9Hk49nmnvh2tD7K13NWjcujfcB1frMMel19ZC2EFrlfYRdpfrNnq5vnq-uB09PN7cXZw9jAwvOB0JOeamyHNZUSlMZnlprBGlBKtFYblkpTQWDBMk58JakaghIumKg5FMZtvoaJG3Dc1Hn36gpi4a8F7X0PRR0WzMSEFoIRI9-EMnTR_q9DpFOc8E4VQM6nihTGhiDFCpNrhp-pmiRA29V6n36qv3ye4vM_blFOyP_G52AodLoKPRvgq6Ni7-ujHPJZdFcqcLN3Me5v9XVOf3L4vSn8urmTA</recordid><startdate>201307</startdate><enddate>201307</enddate><creator>Rahnama'i, Mohammad S.</creator><creator>Koeveringe, Gommert A.</creator><creator>Hohnen, Ramona</creator><creator>Ona, Samsya</creator><creator>Kerrebroeck, Philip E.V.</creator><creator>Wachter, Stefan G.G.</creator><general>Wiley-Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7X8</scope></search><sort><creationdate>201307</creationdate><title>Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder</title><author>Rahnama'i, Mohammad S. ; Koeveringe, Gommert A. ; Hohnen, Ramona ; Ona, Samsya ; Kerrebroeck, Philip E.V. ; Wachter, Stefan G.G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>cGMP</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 5 - analysis</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism</topic><topic>detrusor</topic><topic>guinea pig</topic><topic>Guinea Pigs</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>phosphodiesterase inhibitor type 5 (PDE5)</topic><topic>urinary bladder</topic><topic>Urinary Bladder - chemistry</topic><topic>Urinary Bladder - metabolism</topic><topic>vardenafil</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahnama'i, Mohammad S.</creatorcontrib><creatorcontrib>Koeveringe, Gommert A.</creatorcontrib><creatorcontrib>Hohnen, Ramona</creatorcontrib><creatorcontrib>Ona, Samsya</creatorcontrib><creatorcontrib>Kerrebroeck, Philip E.V.</creatorcontrib><creatorcontrib>Wachter, Stefan G.G.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahnama'i, Mohammad S.</au><au>Koeveringe, Gommert A.</au><au>Hohnen, Ramona</au><au>Ona, Samsya</au><au>Kerrebroeck, Philip E.V.</au><au>Wachter, Stefan G.G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2013-07</date><risdate>2013</risdate><volume>112</volume><issue>2</issue><spage>246</spage><epage>257</epage><pages>246-257</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><coden>BJINFO</coden><abstract>Objective To study PDE5 localisation by visualising the product of phosphodiesterase type 5 (PDE5) inhibition, namely cGMP, to determine the site of action of inhibitors in the urinary bladder. Materials and Methods Bladders of nine male guinea pigs were dissected and treated in wells containing 2 mL Krebs' solution and 1 μM of the specific PDE5 inhibitor vardenafil at 36 °C for 30 min. After stimulating tissues with 100 μM of the nitric oxide (NO) donor diethylamine‐NONOate for 10 min, the tissues were snap‐frozen and 9–10 μm sections were cut. Sections were examined for cGMP immunoreactivity and also stained for vimentin, a marker for interstitial cells and the neuromarkers protein gene product 9.5 (PGP9.5), synaptic vesicle protein 2 (SV2), neurofilament (NF) and calcitonin gene‐related peptide (CGRP), using the two‐step indirect immunohistochemistry technique. Results After PDE5 inhibition, cGMP was found to be present in the urothelium, suburothelial interstitial cells and endothelium of blood vessels. cGMP was not expressed in nerves positive for CGRP, NF and SV2, and was expressed only in very few efferent nerves positive for PGP9.5. Conclusion Our data show that the possible sites of action of PDE5 inhibition in the bladder are the urothelium, suburothelial interstitial cells and blood vessels, rather than the bladder nerve fibres.</abstract><cop>Oxford</cop><pub>Wiley-Blackwell</pub><pmid>23452226</pmid><doi>10.1111/bju.12031</doi><tpages>12</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1464-4096
ispartof BJU international, 2013-07, Vol.112 (2), p.246-257
issn 1464-4096
1464-410X
language eng
recordid cdi_proquest_miscellaneous_1372080185
source Wiley-Blackwell Read & Publish Collection
subjects Animals
Biological and medical sciences
cGMP
Cyclic Nucleotide Phosphodiesterases, Type 5 - analysis
Cyclic Nucleotide Phosphodiesterases, Type 5 - metabolism
detrusor
guinea pig
Guinea Pigs
Male
Medical sciences
Nephrology. Urinary tract diseases
phosphodiesterase inhibitor type 5 (PDE5)
urinary bladder
Urinary Bladder - chemistry
Urinary Bladder - metabolism
vardenafil
title Distribution of phosphodiesterase type 5 (PDE5) in the lateral wall of the guinea pig urinary bladder
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T00%3A26%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Distribution%20of%20phosphodiesterase%20type%205%20(PDE5)%20in%20the%20lateral%20wall%20of%20the%20guinea%20pig%20urinary%20bladder&rft.jtitle=BJU%20international&rft.au=Rahnama'i,%20Mohammad%20S.&rft.date=2013-07&rft.volume=112&rft.issue=2&rft.spage=246&rft.epage=257&rft.pages=246-257&rft.issn=1464-4096&rft.eissn=1464-410X&rft.coden=BJINFO&rft_id=info:doi/10.1111/bju.12031&rft_dat=%3Cproquest_cross%3E3104433491%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4841-5974c8669f195c3d4bcdc5b9eda58d492b9cdec250645dd5866c059f1f4ec9293%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1443504155&rft_id=info:pmid/23452226&rfr_iscdi=true